{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:24:03Z","timestamp":1790663043104,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00723","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T06:14:55Z","timestamp":1554790495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia"],"prefix":"10.3389","volume":"10","author":[{"given":"Laura","family":"Matarazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiordiligie","family":"Casilag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Cayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Faveeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Carnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Sirard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.cmi.2018.02.004","article-title":"Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries","volume":"24","author":"Ieven","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"B2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-physiol-021014-071937","article-title":"Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling","volume":"77","author":"Quinton","year":"2015","journal-title":"Annu Rev Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tim.2013.12.007","article-title":"Overcoming the current deadlock in antibiotic research","volume":"22","author":"Sch\u00e4berle","year":"2014","journal-title":"Trends Microbiol"},{"key":"B5","unstructured":"Global Action Plan on Antimicrobial Resistance [Internet]."},{"key":"B6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fimmu.2013.00387","article-title":"Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases","volume":"4","author":"Savva","year":"2013","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrmicro2745","article-title":"Modulating immunity as a therapy for bacterial infections","volume":"10","author":"Hancock","year":"2012","journal-title":"Nat Rev Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/650203","article-title":"Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection","volume":"201","author":"Kinnebrew","year":"2010","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07250","article-title":"Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits","volume":"455","author":"Brandl","year":"2008","journal-title":"Nature."},{"key":"B10","doi-asserted-by":"publisher","first-page":"327ra25","DOI":"10.1126\/scitranslmed.aad6663","article-title":"TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus","volume":"8","author":"Abt","year":"2016","journal-title":"Sci Transl Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.tim.2017.10.008","article-title":"Compartmentalized antimicrobial defenses in response to flagellin","volume":"26","author":"Vijayan","year":"2018","journal-title":"Trends Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.4049\/jimmunol.180.12.8280","article-title":"Flagellin treatment protects against chemicals, bacteria, viruses, and radiation","volume":"180","author":"Vijay-Kumar","year":"2008","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1128\/IAI.01196-10","article-title":"Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis","volume":"79","author":"Jarchum","year":"2011","journal-title":"Infect Immun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.4049\/jimmunol.178.8.4717","article-title":"Cutting edge: Tlr5-\/- mice are more susceptible to Escherichia coli urinary tract infection","volume":"178","author":"Andersen-Nissen","year":"2007","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1128\/IAI.00224-10","article-title":"Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection","volume":"78","author":"Mu\u00f1oz","year":"2010","journal-title":"Infect Immun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4049\/jimmunol.1000509","article-title":"Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide","volume":"185","author":"Yu","year":"2010","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.1256999","article-title":"Viral infection","volume":"346","author":"Zhang","year":"2014","journal-title":"Science."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e96165","DOI":"10.1371\/journal.pone.0096165","article-title":"Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice","volume":"9","author":"Hossain","year":"2014","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1002\/eji.201444490","article-title":"Flagellin-induced expression of CXCL10 mediates direct fungal killing and recruitment of NK cells to the cornea in response to Candida albicans infection","volume":"44","author":"Liu","year":"2014","journal-title":"Eur J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1128\/AAC.01210-15","article-title":"A toll-like receptor 5 agonist improves the efficacy of antibiotics in treatment of primary and influenza virus-associated pneumococcal mouse infections","volume":"59","author":"Porte","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/eji.200838907","article-title":"Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin","volume":"39","author":"Janot","year":"2009","journal-title":"Eur J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/mi.2013.66","article-title":"Airway structural cells regulate TLR5-mediated mucosal adjuvant activity","volume":"7","author":"Van Maele","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1016\/j.vaccine.2015.05.022","article-title":"Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract","volume":"33","author":"Fougeron","year":"2015","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cmi.2017.12.004","article-title":"Assessment and modelling of antibacterial combination regimens","volume":"24","author":"Rao","year":"2017","journal-title":"Clin Microbiol Infect."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/JCM.01121-14","article-title":"When does 2 plus 2 equal 5? A review of antimicrobial synergy testing","volume":"52","author":"Doern","year":"2014","journal-title":"J Clin Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/infdis\/140.4.629","article-title":"Comparison of techniques for measurement of in vitro antibiotic synergism","volume":"140","author":"Norden","year":"1979","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/infdis\/jiu106","article-title":"Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection","volume":"210","author":"Van Maele","year":"2014","journal-title":"J Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1074\/jbc.M111.304758","article-title":"Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages","volume":"287","author":"Paget","year":"2012","journal-title":"J Biol Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.4049\/jimmunol.1002348","article-title":"Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia","volume":"186","author":"Paget","year":"2011","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ni.1942","article-title":"Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A","volume":"11","author":"De Santo","year":"2010","journal-title":"Nat Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.4049\/jimmunol.181.3.2036","article-title":"Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity","volume":"181","author":"Nempont","year":"2008","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2977","DOI":"10.1371\/journal.pntd.0002977","article-title":"Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi","volume":"8","author":"Planer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1128\/IAI.00789-06","article-title":"Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection","volume":"74","author":"McNamee","year":"2006","journal-title":"Infect Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4049\/jimmunol.1002194","article-title":"Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice","volume":"186","author":"Kudva","year":"2011","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1128\/IAI.00298-15","article-title":"Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease","volume":"83","author":"Rynda-Apple","year":"2015","journal-title":"Infect Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1128\/IAI.72.11.6676-6679.2004","article-title":"Mucosal administration of flagellin induces innate immunity in the mouse lung","volume":"72","author":"Honko","year":"2004","journal-title":"Infect Immun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.4049\/jimmunol.172.11.6922","article-title":"Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response","volume":"172","author":"Didierlaurent","year":"2004","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/mi.2017.71","article-title":"Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense","volume":"11","author":"Leiva-Ju\u00e1rez","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"L219","DOI":"10.1152\/ajplung.00078.2016","article-title":"Lung epithelial MyD88 drives early pulmonary clearance of Pseudomonas aeruginosa by a flagellin dependent mechanism","volume":"311","author":"Anas","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fcimb.2013.00007","article-title":"Understanding the pneumococcus: transmission and evolution","volume":"3","author":"Donkor","year":"2013","journal-title":"Front Cell Infect Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.phrs.2018.07.005","article-title":"Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives","volume":"134","author":"de Velde","year":"2018","journal-title":"Pharmacol Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T06:15:05Z","timestamp":1554790505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2019.00723"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00723","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"article-number":"723"}}